Heartflow Inc
HTFLHealthcare·Health Information Services·USA·Mid·NASD·Nov 13 • 7:02 AM ET
59.00-0.92 (-1.54%)
2026-11-13 13:21 CET
Market cap
$5.13B
Revenue, TTM
238.66 USD m
Net income, TTM
-79.02 USD m
Free cash flow, TTM
-56.07 USD m
EPS diluted, TTM
-0.92
Price
HTFL against its 20, 50 and 200-day averagesPatternshover a marker to name it
2.7% under the 52-week high of 60.66 on 11 Nov 2026. 52-week low 20.13 on 13 Feb 2026. Last 15 sessions, 18.8% high to low
Volume 0.02× normal · the line is the 50-bar volume average
Setup. RS line 100
CANSLIM 6 of 6
VCP 5 of 6 — fails: Average True Range: Under 2
Minervini 4 of 4
Zanger 4 of 5 — fails: Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 2 of 4 — fails: EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 2 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%) — not on the tape: P/E: Under 25
Value 1 of 4 — fails: P/B: Under 2; Return on Equity: Over +15% — not on the tape: P/E: Under 15
Income 0 of 4 — fails: Dividend Growth: Growing 2+ Years — not on the tape: Dividend Yield: Over 2%; Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 4 of 4
Accumulation 4 of 4
Relative Strength 2 of 3 — fails: Performance: Year +100%
Profile
HTFL52-week range, 96% of the way up
20.1360.66
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in San Francisco, CA.
| Index | RUT |
|---|---|
| Employees | 843 |
| IPO | Aug 08, 2025 |
| Beta | 2.51 |
| ATR, 14d | 3.23 |
| Rel volume | 0.02 |
| Short float | 8.77% |
| Insider own | 25.40% |
| Inst own | 83.39% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | $5.13B |
| Enterprise Value | 4.99B |
| Income | -79.02M |
| Sales | 238.66M |
| Book / share | 3.22 |
| Cash / share | 1.93 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 843 |
| IPO | Aug 08, 2025 |
Ratios
| Price / earnings | - |
|---|---|
| Forward price / earnings | - |
| Price / earnings / growth | - |
| Price / sales | 21.49 |
| Price / book | 18.33 |
| Price / cash | 30.58 |
| Price / free cash flow | - |
| Value / cash profit | - |
| Value / sales | 20.90 |
| Quick Ratio | 4.24 |
| Current Ratio | 4.24 |
| Debt / equity | 0.09 |
| Long-term debt / equity | 0.07 |
| Options and short | Yes / Yes |
Earnings
| Earnings / share | -0.92 |
|---|---|
| Earnings next year | -0.27 |
| Earnings next quarter | -0.08 |
| Earnings this year | 77.79% |
| Earnings next year | 23.63% |
| Earnings growth, 5 years | - |
| Past earnings growth | 5.20% - |
| Past sales growth | 42.10% - |
| Earnings vs last year | - |
| Sales vs last year | - |
| Earnings vs last quarter | 78.35% |
| Sales vs last quarter | 57.44% |
| Earnings | Nov 12 AMC |
| Surprise | 70.85% 11.75% |
Ownership
| Insiders own | 25.40% |
|---|---|
| Insider trades | -2.19% |
| Institutions own | 83.39% |
| Institution trades | 32.78% |
| Return on assets | -21.96% |
| Return on equity | -29.43% |
| Return on capital | -26.20% |
| Gross Margin | 81.85% |
| Operating margin | -29.97% |
| Profit Margin | -33.11% |
| 20-day average | 4.57% |
| 50-day average | 13.19% |
| 200-day average | 67.30% |
Technical
| Shares out | 87.79M |
|---|---|
| Shares floating | 64.87M |
| Short / float | 8.77% |
| Short ratio | 2.76 |
| Short interest | 5.69M |
| 52-week high | 60.66 -2.7% |
| 52-week low | 20.13 +193.1% |
| Volatility | 5.95% 6.21% |
| Average range | 3.23 |
| Strength index | 59.20 |
| Market sensitivity | 2.51 |
| Relative volume | 0.02 |
| Avg Volume | 2.06M |
| Volume | 1,964 |
Performance
| Perf Week | 12.59% |
|---|---|
| Perf Month | 15.89% |
| Perf Quarter | 40.67% |
| Perf Half Y | 108.36% |
| Perf YTD | 102.39% |
| Perf Year | 90.68% |
| Perf 3Y | - |
| Perf 5Y | - |
| Perf 10Y | - |
| Recommendation | 1.33 |
| Target Price | 59.12 |
| Prev Close | 59.92 |
| Price | 59.00 |
| Change % | -1.54% |
Analyst ratings
latest 9 of 9| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Sep 09, 2026 | Resumed | UBS | Neutral | $55 | -6.8% |
| Jul 31, 2026 | Initiated | Robert W. Baird | Outperform | $34 | -42.4% |
| May 04, 2026 | Initiated | William Blair | Outperform | ||
| Jan 28, 2026 | Initiated | Wells Fargo | Overweight | $38 | -35.6% |
| Sep 02, 2025 | Initiated | Stifel | Buy | $35 | -40.7% |
| Sep 02, 2025 | Initiated | Piper Sandler | Overweight | $38 | -35.6% |
| Sep 02, 2025 | Initiated | Morgan Stanley | Equal-Weight | $35 | -40.7% |
| Sep 02, 2025 | Initiated | JP Morgan | Overweight | $36 | -39.0% |
| Sep 02, 2025 | Initiated | Canaccord Genuity | Buy | $35 | -40.7% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| TEM | Tempus AI Inc | 14.02B |
| RDNT | Radnet Inc | 5.99B |
| IRTC | iRhythm Holdings Inc | 3.16B |
| GEHC | GE HealthCare Technologies Inc | 37.08B |
| SOPH | SOPHiA Genetics SA | 669.10M |
| BFLY | Butterfly Network Inc | 1.81B |
| PHG | Koninklijke Philips NV ADR | 29.59B |
| CBLL | Ceribell Inc | 1.03B |
| NNOX | Nano X Imaging Ltd | 25.21M |
| HSCS | HeartSciences Inc | 11.23M |
Insider trading
latest 14 of 98| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| Farquhar John C.M. | Chief Executive Officer | Nov 10 '26 | Option Exercise | 2.22 | 15,620 | 34,676 | 290,883 | Nov 10 06:59 PM |
| Farquhar John C.M. | Chief Executive Officer | Nov 10 '26 | Sale | 55.74 | 38,900 | 2,168,286 | 251,983 | Nov 10 06:59 PM |
| Verghese Vikram | Chief Financial Officer | Nov 09 '26 | Sale | 53.15 | 3,587 | 190,649 | 149,587 | Nov 10 06:52 PM |
| Farquhar John C.M. | Officer | Nov 10 '26 | Proposed Sale | 55.74 | 38,900 | 2,168,286 | Nov 10 09:47 AM | |
| Verghese Vikram | Officer | Nov 09 '26 | Proposed Sale | 53.15 | 3,587 | 190,649 | Nov 09 10:08 AM | |
| Rogers Campbell | Chief Medical Officer | Oct 22 '26 | Option Exercise | 6.54 | 17,430 | 114,025 | 97,386 | Oct 26 06:00 PM |
| Rogers Campbell | Chief Medical Officer | Oct 22 '26 | Sale | 55.01 | 23,933 | 1,316,554 | 73,453 | Oct 26 06:00 PM |
| Rogers Campbell | Officer | Oct 22 '26 | Proposed Sale | 55.01 | 23,933 | 1,316,554 | Oct 22 11:09 AM | |
| Rogers Campbell | Member of immediate family of | Oct 22 '26 | Proposed Sale | 55.01 | 5,654 | 311,027 | Oct 22 10:34 AM | |
| Farquhar John C.M. | Chief Executive Officer | Oct 12 '26 | Sale | 49.57 | 38,900 | 1,928,195 | 283,014 | Oct 14 06:05 PM |
| Farquhar John C.M. | Officer | Oct 12 '26 | Proposed Sale | 49.57 | 38,900 | 1,928,195 | Oct 13 08:21 AM | |
| Rogers Campbell | Chief Medical Officer | Sep 18 '26 | Option Exercise | 7.94 | 13,179 | 104,588 | 99,638 | Sep 21 06:19 PM |
| Rogers Campbell | Chief Medical Officer | Sep 18 '26 | Sale | 50.15 | 19,682 | 987,052 | 79,956 | Sep 21 06:19 PM |
| Verghese Vikram | Chief Financial Officer | Sep 18 '26 | Sale | 50.75 | 16,766 | 850,926 | 155,183 | Sep 18 08:46 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 696.31B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.86B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 80.23B |
| VBR | Vanguard Morningstar Small-Cap Value ETF | AUM: 37.88B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.25B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.79B |
| VTWO | Vanguard Russell 2000 Index ETF | AUM: 16.90B |
| SCHA | Schwab U.S. Small-Cap ETF | AUM: 22.44B |
| FESM | Fidelity Enhanced Small Cap Core ETF | AUM: 6.90B |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | AUM: 1.37B |
News
latest 14 of 138- Heartflow Beats Big And Raises Again As Plaque Ramps, But A 51% Run Leaves Little Room For The Implied Q4 Slowdown (Earnings Whispers)
- HeartFlow: Q3 Earnings Snapshot (Associated Press)
- Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance (GlobeNewswire)
- Heartflow Must Prove Its Flat Second-Half Guide Is Conservative After A 39% Rally (Earnings Whispers) -8.17%
- AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry (GlobeNewswire) -7.72%
- TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients (GlobeNewswire)
- Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026 (GlobeNewswire) +5.65% +8.96%
- Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half (GlobeNewswire)
- Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference (GlobeNewswire)
- This AI-Tied IPO Stock Just Broke Out On Its 'Outsized' Guidance Boost (Investor's Business Daily) +35.70%
- HeartFlow Inc (HTFL) (Q2 2026) Earnings Call Highlights: Revenue Surges 48% and Plaque Momentum ... (GuruFocus.com)
- HeartFlow: Q2 Earnings Snapshot (Associated Press)
- Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance (GlobeNewswire)
- HeartFlow Inc (HTFL) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Quarterly earnings
2026Q3 EPS -0.030 beat -0.103, from -0.270 a year earlier. Sales 72.86 beat 65.19, from 46.28 a year earlier
The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.
| Period | Reported | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | Surprise | Year-ago quarter | Analysts | Next session |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026Q3ended 2026-09-30 | 2026-11-12 16:30 | -0.030 | -0.103 | -0.132 | 72.86 | 65.19 | EPS -70.8% · sales +11.8% | vs 2025Q3, year-ago quarter · EPS -88.9% · sales +57.4% | 8 EPS · 9 sales | Open -1.40% vs SPY -0.14%. Close -1.54% vs SPY +0.28% |
| 2026Q2ended 2026-06-30 | 2026-08-13 16:30 | -0.070 | -0.134 | -0.182 | 64.08 | 56.64 | EPS -47.6% · sales +13.1% | vs 2025Q2, year-ago quarter · EPS -54.3% · sales +48.0% | 8 | Open +25.96% vs SPY +0.08%. Close +35.70% vs SPY -0.20% |
| 2026Q1ended 2026-03-31 | 2026-05-14 16:30 | -0.160 | -0.188 | -0.320 | 52.59 | 49.71 | EPS -14.7% · sales +5.8% | vs 2025Q1, year-ago quarter · EPS -65.3% · sales +41.4% | 7 EPS · 6 sales | Open -9.89% vs SPY -0.85%. Close -12.17% vs SPY -1.20% |
| 2025Q4ended 2025-12-31 | 2026-03-18 16:30 | -0.120 | -0.169 | -0.286 | 49.13 | 46.58 | EPS -29.0% · sales +5.5% | - | 6 EPS · 5 sales | Open -1.85% vs SPY -0.67%. Close +1.65% vs SPY -0.25% |
| 2025Q3ended 2025-09-30 | 2025-11-12 16:30 | -0.270 | -0.242 | -0.609 | 46.28 | 42.03 | EPS +11.4% · sales +10.1% | - | 4 | Open -3.05% vs SPY -0.42%. Close -13.43% vs SPY -1.66% |
| 2025Q2ended 2025-06-30 | 2025-09-03 12:00 | -0.153 | -0.213 | -0.110 | 43.31 | 43.20 | EPS -28.1% · sales +0.2% | - | 4 | Open +0.39% vs SPY +0.37%. Close +0.39% vs SPY +0.54% |
| 2025Q1ended 2025-03-31 | 2025-05-28 12:00 | -0.461 | - | -0.399 | 37.20 | - | EPS - · sales - | - | - | - |
| 2026Q4ended 2026-12-31 | - | - | -0.085 | - | - | 70.72 | EPS - · sales - | vs 2025Q4, year-ago quarter · EPS - · sales - | 8 EPS · 9 sales | - |
| 2027Q1ended 2027-03-31 | - | - | -0.086 | - | - | 73.66 | EPS - · sales - | vs 2026Q1, year-ago quarter · EPS - · sales - | 6 | - |
| 2027Q2ended 2027-06-30 | - | - | -0.067 | - | - | 80.30 | EPS - · sales - | vs 2026Q2, year-ago quarter · EPS - · sales - | 6 | - |
| 2027Q3ended 2027-09-30 | - | - | -0.051 | - | - | 82.91 | EPS - · sales - | vs 2026Q3, year-ago quarter · EPS - · sales - | 6 | - |
| 2027Q4ended 2027-12-31 | - | - | -0.048 | - | - | 85.51 | EPS - · sales - | vs 2026Q4, year-ago quarter · EPS - · sales - | 6 | - |
| 2028Q1ended 2028-03-31 | - | - | 0.009 | - | - | 89.34 | EPS - · sales - | vs 2027Q1, year-ago quarter · EPS - · sales - | 2 EPS · 1 sales | - |
| 2028Q2ended 2028-06-30 | - | - | 0.026 | - | - | 93.47 | EPS - · sales - | vs 2027Q2, year-ago quarter · EPS - · sales - | 2 EPS · 1 sales | - |
| 2028Q3ended 2028-09-30 | - | - | 0.032 | - | - | 95.58 | EPS - · sales - | vs 2027Q3, year-ago quarter · EPS - · sales - | 2 EPS · 1 sales | - |
| 2028Q4ended 2028-12-31 | - | - | 0.029 | - | - | 97.88 | EPS - · sales - | vs 2027Q4, year-ago quarter · EPS - · sales - | 2 EPS · 1 sales | - |
Annual earnings
2025FY EPS -1.620 beat -1.932. Sales 176.03 beat 173.41
earnings feed, not the snapshot. Not the statement ratio.
| Period | EPS adjusted | EPS est | EPS reported | Sales act, USD m | Sales est, USD m | P/E, earnings feed |
|---|---|---|---|---|---|---|
| 2030FYestimate | - | 0.685 | - | - | 571.05 | 86.13 |
| 2029FYestimate | - | 0.320 | - | - | 474.29 | 184.36 |
| 2028FYestimate | - | 0.066 | - | - | 385.89 | 899.33 |
| 2027FYestimate | - | -0.275 | - | - | 318.87 | - |
| 2026FYestimate | - | -0.360 | - | - | 256.86 | - |
| 2025FY | -1.620 | -1.932 | -3.170 | 176.03 | 173.41 | - |
Quarterly results
2026Q3 revenue 72.86, from 46.28 a year earlier. Operating margin -19.0%, from -32.6% a year earlier
From the quarterly statement. Not an estimate.
Estimate revisions
Latest snapshot of each period and type. 2026FY E -0.37 per share.
| Period | Type | Scale | Date | Mean | vs prior date |
|---|---|---|---|---|---|
| 2026FY | E | per share | 2026-11-13 | -0.37 | -10.8% |
| 2026Q4 | E | per share | 2026-11-13 | -0.08 | -7.2% |
| 2026FY | R | per share | 2026-11-13 | -0.78 | -3.5% |
| 2026Q4 | R | per share | 2026-11-13 | -0.15 | 0.0% |
| 2026Q4 | S | per share | 2026-11-13 | 70.72 | +6.0% |
| 2026FY | S | - | 2026-11-13 | 256.86 | +3.3% |
| 2026Q3 | E | per share | 2026-11-02 | -0.10 | +0.2% |
| 2026Q3 | S | per share | 2026-11-02 | 65.19 | 0.0% |
| 2026Q3 | R | per share | 2026-10-28 | -0.15 | 0.0% |
| 2026Q2 | E | per share | 2026-08-11 | -0.13 | 0.0% |
| 2026Q2 | R | per share | 2026-08-08 | -0.18 | +3.0% |
| 2026Q2 | S | per share | 2026-07-30 | 56.64 | +0.0% |
| 2026Q1 | E | per share | 2026-05-01 | -0.19 | +0.3% |
| 2026Q1 | S | per share | 2026-05-01 | 49.71 | +0.0% |
| 2026Q1 | R | per share | 2026-04-30 | -0.20 | -3.2% |
| 2025Q4 | E | per share | 2026-03-06 | -0.17 | +0.5% |
| 2025Q4 | R | per share | 2026-03-06 | -0.27 | +0.6% |
| 2025Q4 | S | per share | 2026-03-06 | 46.58 | +0.1% |
| 2025Q3 | E | per share | 2025-09-25 | -0.24 | +16.9% |
| 2025Q3 | R | per share | 2025-09-25 | -0.36 | +25.9% |
| 2025Q3 | S | per share | 2025-09-19 | 42.03 | +0.0% |
| 2025Q2 | E | per share | 2025-09-01 | -0.21 | +0.2% |
| 2025Q2 | S | per share | 2025-09-01 | 43.20 | +0.1% |
| 2025Q2 | R | per share | 2025-08-29 | -0.25 | - |
Estimate history
| Metric | 2023 | 2024 | 2025 | TTM | MRQ |
|---|---|---|---|---|---|
| EPS per share | -1.524 | -1.188 | -1.37 | -0.9198 | - |
| Sales USD millions | 87 | 126 | 176 | 239 | - |
| Shares million shares | 81 | 81 | 85 | - | 88 |
| Metric | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| EPS per share | -0.258 | -0.399 | -0.11 | -0.609 | -0.286 | -0.32 | -0.182 | -0.132 |
| Sales USD millions | 27 | 37 | 43 | 46 | 49 | 53 | 64 | 73 |
| Shares million shares | 81 | 81 | 83 | 83 | 85 | 86 | 87 | 88 |
Income statement, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 |
|---|---|---|---|---|
| Total Revenue | 238.66 | 176.03+39.9% | 125.81+44.3% | 87.17 |
| Cost of Goods Sold Incl. D&A | 43.32 | 40.84+30.2% | 31.36+7.7% | 29.12 |
| Gross Profit | 195.33 | 135.20+43.1% | 94.45+62.7% | 58.05 |
| Selling, General and Administrative Excl. Other | 266.85 | 199.26+28.0% | 155.67+18.9% | 130.97 |
| Research and Development | 96.03 | 64.92+49.2% | 43.52+21.4% | 35.85 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -71.52 | -64.07 | -61.22 | -72.91 |
| Interest Expense | 0.02 | 15.17-33.4% | 22.77-7.8% | 24.69 |
| Unusual Expense | 16.79 | 42.94+158.4% | 16.62+406.7% | 3.28 |
| Net Income Before Taxes | -79.12 | -116.87 | -96.37 | -95.11 |
| Income Taxes | -0.10 | -0.08-260.0% | 0.05-90.9% | 0.55 |
| Consolidated Net Income | -79.02 | -116.79 | -96.43 | -95.66 |
| Net Income From Continuing Operations | -79.02 | -116.79 | -96.43 | -95.66 |
| Net Income | -79.02 | -116.79 | -96.43 | -123.69 |
| EPS (Recurring) per share | -0.77 | -1.02 | -1.04 | -1.50 |
| EPS (Basic, Before Extraordinaries) per share | -0.92 | -1.37 | -1.19 | -1.52 |
| EPS (Diluted) per share | -0.92 | -1.37 | -1.19 | -1.52 |
| EBITDA | -62.08 | -55.49 | -53.13 | -65.28 |
| Non-Operating Income (Expense) | 9.20 | 5.32+25.8% | 4.23-26.8% | 5.78 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 21.57 | 11.03+36.7% | 8.07-18.3% | 9.88 |
| Price To Sales Ratio ratio | - | 14.12 | - | - |
| Gross Margin % | 81.85 | 76.80 | 75.07 | 66.59 |
| Operating Margin % | -29.97 | -36.39 | -48.66 | -83.64 |
| Net Margin % | -33.11 | -66.35 | -76.65 | -141.89 |
| Shares Outstanding million shares | 87.79 | 85.28+5.1% | 81.170.0% | 81.17 |
| Market Capitalization | 5,210.26 | 5,210.26+102.5% | 2,572.64 | - |
Income statement, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q13/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 72.86+57.4% | 64.08+47.6% | 52.59+41.4% | 49.13 | 46.28 | 43.42 | 37.20+38.6% | 26.84 |
| Cost of Goods Sold Incl. D&A | 11.94+9.9% | 10.89+2.3% | 10.42+12.5% | 10.07 | 10.86 | 10.65 | 9.26+24.8% | 7.42 |
| Gross Profit | 60.92+72.0% | 53.19+62.3% | 42.16+50.9% | 39.06 | 35.41 | 32.78 | 27.94+43.9% | 19.42 |
| Selling, General and Administrative Excl. Other | 74.76+48.0% | 71.09+52.9% | 64.19+41.3% | 56.81 | 50.51 | 46.49 | 45.44+28.1% | 35.48 |
| Research and Development | 29.49+70.5% | 26.26+74.7% | 21.62+55.3% | 18.66 | 17.30 | 15.03 | 13.92+47.5% | 9.44 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -13.85 | -17.90 | -22.02 | -17.75 | -15.10 | -13.71 | -17.50 | -16.06 |
| Interest Expense | 0.01-99.7% | 0.00-100.0% | 0.00-100.0% | 0.01 | 3.45 | 6.62 | 5.09-18.4% | 6.24 |
| Unusual Expense | 0.00-100.0% | 0.00 | 7.48-29.8% | 9.31 | 33.66 | -10.68 | 10.65+17650.0% | 0.06 |
| Net Income Before Taxes | -11.48 | -15.72 | -27.36 | -24.56 | -50.83 | -9.14 | -32.34 | -21.00 |
| Income Taxes | 0.02-33.3% | 0.02-66.7% | 0.02 | -0.17 | 0.03 | 0.06 | 0.00 | -0.07 |
| Consolidated Net Income | -11.51 | -15.74 | -27.38 | -24.39 | -50.85 | -9.20 | -32.34 | -20.93 |
| Net Income From Continuing Operations | -11.51 | -15.74 | -27.38 | -24.39 | -50.85 | -9.20 | -32.34 | -20.93 |
| Net Income | -11.51 | -15.74 | -27.38 | -24.39 | -50.85 | -9.20 | -32.34 | -20.93 |
| EPS (Recurring) per share | -0.13 | -0.18 | -0.26 | -0.21 | -0.33 | -0.20 | -0.31 | -0.26 |
| EPS (Basic, Before Extraordinaries) per share | -0.13 | -0.18 | -0.32 | -0.29 | -0.61 | -0.11 | -0.40 | -0.26 |
| EPS (Diluted) per share | -0.13 | -0.18 | -0.32 | -0.29 | -0.61 | -0.11 | -0.40 | -0.26 |
| EBITDA | -11.35 | -15.64 | -19.59 | -15.50 | -13.01 | -11.57 | -15.41 | -14.20 |
| Non-Operating Income (Expense) | 2.37+71.7% | 2.18+319.2% | 2.15+138.9% | 2.51 | 1.38 | 0.52 | 0.90-33.8% | 1.36 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 5.98+91.1% | 6.25+251.1% | 5.18+108.0% | 4.16 | 3.13 | 1.78 | 2.49+15.8% | 2.15 |
| Price To Sales Ratio ratio | - | 11.95 | 10.89 | 14.12 | - | - | - | - |
| Gross Margin % | 83.61 | 83.00 | 80.18 | 79.51 | 76.53 | 75.48 | 75.10 | 72.36 |
| Operating Margin % | -19.00 | -27.93 | -41.88 | -36.13 | -32.63 | -31.58 | -47.04 | -59.82 |
| Net Margin % | -15.79 | -24.57 | -52.07 | -49.65 | -109.89 | -21.18 | -86.94 | -77.98 |
| Shares Outstanding million shares | 87.79+5.2% | 86.72+4.0% | 86.11+6.1% | 85.28 | 83.47 | 83.40 | 81.170.0% | 81.17 |
| Market Capitalization | 5,210.26+85.6% | 2,530.31-12.1% | 2,086.48 | 2,482.38 | 2,807.11 | 2,877.17 | - | - |
Balance sheet, annual
| Metric | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 |
|---|---|---|---|
| Cash & Short Term Investments | 176.79+243.1% | 51.52-58.0% | 122.77 |
| Short Term Receivables | 29.34+19.1% | 24.64+19.9% | 20.55 |
| Inventories | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 7.41+101.4% | 3.68+15.7% | 3.18 |
| Total Current Assets | 213.53+167.5% | 79.83-45.5% | 146.49 |
| Net Property, Plant & Equipment | 26.07-6.0% | 27.73-10.2% | 30.88 |
| Total Investments and Advances | 108.07+2395.8% | 4.33-3.1% | 4.47 |
| Other Assets | 11.77+72.6% | 6.82+112.5% | 3.21 |
| Total Assets | 359.45+202.8% | 118.70-35.9% | 185.05 |
| Short Term Debt Incl. Current Port. of LT Debt | 5.92+9.2% | 5.42+5.4% | 5.14 |
| Accounts Payable | 3.17+10.5% | 2.87-0.7% | 2.89 |
| Other Current Liabilities | 33.28+31.4% | 25.32+2.1% | 24.79 |
| Total Current Liabilities | 42.37+26.1% | 33.60+2.4% | 32.81 |
| Long Term Debt | 16.13-89.6% | 154.97-0.3% | 155.46 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.30-98.6% | 21.05+264.8% | 5.77 |
| Total Liabilities | 58.80-71.9% | 209.62+8.0% | 194.05 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00-100.0% | 768.570.0% | 768.57 |
| Common Equity | 300.65 | -859.48 | -777.56 |
| Total Shareholders Equity | 300.65 | -90.92 | -9.00 |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 |
| Total Equity | 300.65 | -90.92 | -9.00 |
| Total Liabilities & Stockholders Equity | 359.45+202.8% | 118.70-35.9% | 185.05 |
| Book Value Per Share per share | 3.53 | -10.59 | -9.58 |
| Tangible Book Value Per Share per share | 3.53 | -10.59 | -9.58 |
| Full-Time Employees people | 843 | - | - |
| Price to Book Ratio ratio | 18.58 | 9.91 | - |
| Return on Assets % | -48.85 | -63.49 | - |
| Return on Equity % | -111.37 | - | - |
| Return on Invested Capital % | -36.87 | -150.55 | -65.31 |
| Quick Ratio ratio | 5.04 | 2.38 | 4.46 |
| Current Ratio ratio | 5.04 | 2.38 | 4.46 |
Cash flow, annual
| Metric | TTM | 2025FY12/31/2025 | 2024FY12/31/2024 | 2023FY12/31/2023 |
|---|---|---|---|---|
| Net Income | -79.02 | -116.79 | -96.43 | -95.66 |
| Depreciation | 9.44 | 8.57+5.9% | 8.09+6.0% | 7.63 |
| Other Funds (Non Cash) | 40.85 | 61.86+104.8% | 30.21+50.1% | 20.13 |
| Funds from Operations | -28.74 | -46.36 | -58.12 | -67.89 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -20.22 | -7.66 | -10.88 | -8.54 |
| Cash from Operating Activities | -48.95 | -54.02 | -69.00 | -76.43 |
| Capital Expenditures | -7.11 | -5.03 | -4.36 | -6.11 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -218.98 | -233.54 | 0.00 | 0.00 |
| Purchase of Investments | -337.47 | -233.54 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 118.49 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -226.09 | -238.57 | -4.36 | -6.11 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 19.02 | 408.45+8857.2% | 4.56-97.3% | 169.32 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | -0.23 |
| Sale of Common Pref Stock | 19.02 | 408.45+8857.2% | 4.56-97.3% | 169.55 |
| Proceedsfrom Stock Options | 5.39 | 405.16 | 0.00-100.0% | 168.96 |
| Issuance or Reduction of Debt, Net | 0.00 | -121.90 | -2.33 | 0.00 |
| Change in Long Term Debt | 0.00 | -121.90 | -2.33 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | -121.90 | -2.33 | 0.00 |
| Net Financing Active Other Cash Flow | -3.42 | -0.51 | 0.00 | 0.00 |
| Other Financing Activities Uses | -3.42 | -0.51 | 0.00 | 0.00 |
| Cash from Financing Activities | 15.60 | 286.04+12669.6% | 2.24-98.7% | 169.32 |
| Exchange Rate Effect | 0.16 | 0.19 | -0.27 | -0.50 |
| Net Change in Cash | -259.29 | -6.36 | -71.39-182.7% | 86.28 |
| Free Cash Flow | -56.07 | -59.05 | -73.36 | -82.54 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | - |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 0.00 |
Balance sheet, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q1 |
|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 167.74-42.4% | 162.55+102.7% | 158.32+44.2% | 176.79 | 291.17 | 80.21 | 109.79 | - |
| Short Term Receivables | 48.20+73.0% | 42.76+44.0% | 35.53+25.5% | 29.34 | 27.86 | 29.69 | 28.31 | - |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Other Current Assets | 10.37+64.3% | 9.45+55.2% | 9.79+139.4% | 7.41 | 6.31 | 6.09 | 4.09 | - |
| Total Current Assets | 226.30-30.4% | 214.76+85.2% | 203.63+43.2% | 213.53 | 325.33 | 115.99 | 142.19 | - |
| Net Property, Plant & Equipment | 24.21-3.5% | 24.88-4.2% | 24.24-11.2% | 26.07 | 25.09 | 25.96 | 27.30 | - |
| Total Investments and Advances | 89.96+1912.5% | 88.99+1890.8% | 101.28+2165.8% | 108.07 | 4.47 | 4.47 | 4.47 | - |
| Other Assets | 14.87+56.5% | 15.83+22.3% | 14.88+42.0% | 11.77 | 9.50 | 12.94 | 10.48 | - |
| Total Assets | 355.34-2.5% | 344.46+116.2% | 344.02+86.5% | 359.45 | 364.40 | 159.36 | 184.44 | - |
| Short Term Debt Incl. Current Port. of LT Debt | 6.88+24.6% | 6.78+23.5% | 6.38+17.1% | 5.92 | 5.52 | 5.49 | 5.45 | - |
| Accounts Payable | 4.92+151.0% | 4.94+176.0% | 5.75+191.9% | 3.17 | 1.96 | 1.79 | 1.97 | - |
| Other Current Liabilities | 41.61+37.0% | 32.37+26.1% | 25.89-28.0% | 33.28 | 30.37 | 25.66 | 35.98 | - |
| Total Current Liabilities | 53.41+41.1% | 44.09+33.8% | 38.02-12.4% | 42.37 | 37.85 | 32.94 | 43.41 | - |
| Long Term Debt | 19.05+17.1% | 20.34-89.8% | 19.97-89.9% | 16.13 | 16.27 | 199.66 | 197.83 | - |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Other Liabilities | 0.34-99.4% | 0.30-99.4% | 0.32-99.5% | 0.30 | 55.72 | 52.99 | 63.63 | - |
| Total Liabilities | 72.80-33.7% | 64.74-77.3% | 58.31-80.9% | 58.80 | 109.83 | 285.59 | 304.87 | - |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Preferred Stock - Carrying Value | 0.00 | 0.00-100.0% | 0.00-100.0% | 0.00 | 0.00 | 768.57 | 768.57 | - |
| Common Equity | 282.54+11.0% | 279.73 | 285.72 | 300.65 | 254.57 | -894.79 | -889.00 | - |
| Total Shareholders Equity | 282.54+11.0% | 279.73 | 285.72 | 300.65 | 254.57 | -126.23 | -120.43 | - |
| Accumulated Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Total Equity | 282.54+11.0% | 279.73 | 285.72 | 300.65 | 254.57 | -126.23 | -120.43 | - |
| Total Liabilities & Stockholders Equity | 355.34-2.5% | 344.46+116.2% | 344.02+86.5% | 359.45 | 364.40 | 159.36 | 184.44 | - |
| Book Value Per Share per share | 3.22+5.6% | 3.23 | 3.32 | 3.53 | 3.05 | -10.73 | -10.95 | - |
| Tangible Book Value Per Share per share | 3.22+5.6% | 3.23 | 3.32 | 3.53 | 3.05 | -10.73 | -10.95 | - |
| Full-Time Employees people | - | - | - | 843 | - | - | 699 | - |
| Price to Book Ratio ratio | 18.58 | 8.84 | 6.90 | 9.56 | -3.14 | -3.22 | - | - |
| Return on Assets % | -21.96 | -46.99 | -42.32 | - | - | - | - | - |
| Return on Equity % | -29.43 | -154.23 | -135.31 | - | - | - | - | - |
| Return on Invested Capital % | -3.81 | -5.25 | -8.96 | -7.70 | -18.78 | -12.52 | -41.79 | - |
| Quick Ratio ratio | 4.24 | 4.87 | 5.36 | 5.04 | 8.60 | 3.52 | 3.28 | - |
| Current Ratio ratio | 4.24 | 4.87 | 5.36 | 5.04 | 8.60 | 3.52 | 3.28 | - |
Cash flow, quarterly
| Metric | 2026Q39/30/2026 | 2026Q26/30/2026 | 2026Q13/31/2026 | 2025Q412/31/2025 | 2025Q39/30/2025 | 2025Q26/30/2025 | 2025Q13/31/2025 | 2024Q13/31/2024 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -11.51 | -15.74 | -27.38 | -24.39 | -50.85 | -9.20 | -32.34 | -20.93 |
| Depreciation | 2.50+19.6% | 2.26+5.6% | 2.43+15.7% | 2.25 | 2.09 | 2.14 | 2.10+12.9% | 1.86 |
| Other Funds (Non Cash) | 7.09-81.9% | 7.31 | 13.20-9.7% | 13.25 | 39.18 | -5.19 | 14.61+292.7% | 3.72 |
| Funds from Operations | -1.92 | -6.17 | -11.75 | -8.90 | -9.59 | -12.24 | -15.63 | -15.35 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 2.24-66.2% | -2.41 | -18.36-843.3% | -1.70 | 6.63 | -15.06 | 2.47 | -6.78 |
| Cash from Operating Activities | 0.32 | -8.58 | -30.10 | -10.60 | -2.96 | -27.30 | -13.17 | -22.13 |
| Capital Expenditures | -1.40 | -1.92 | -1.89 | -1.90 | -1.24 | -0.79 | -1.10 | -1.75 |
| Net Assets From Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Fixed Assets and Businesses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase or Sale of Investments | -9.05 | 23.15 | 0.46 | -233.54 | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchase of Investments | -58.62 | -15.78 | -29.54 | -233.54 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale Or Maturity of Investments | 49.57 | 38.92 | 30.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Investing Activities | -10.45 | 21.22 | -1.43 | -235.44 | -1.24 | -0.79 | -1.10 | -1.75 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 8.70-97.4% | 3.23 | 6.63-91.0% | 0.46 | 335.78 | -1.23 | 73.44+91700.0% | 0.08 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 8.70-97.4% | 3.23 | 6.63-91.0% | 0.46 | 335.78 | -1.23 | 73.44+91700.0% | 0.08 |
| Proceedsfrom Stock Options | 2.50-99.3% | 0.00 | 3.29-95.5% | -0.40 | 334.77 | -2.08 | 72.86 | 0.00 |
| Issuance or Reduction of Debt, Net | 0.00 | 0.00 | 0.00 | 0.00 | -120.83 | -0.55 | -0.52 | 0.00 |
| Change in Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | -120.83 | -0.55 | -0.52 | 0.00 |
| Issuance of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reduction of Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | -120.83 | -0.55 | -0.52 | 0.00 |
| Net Financing Active Other Cash Flow | -1.26 | -1.17 | -0.47 | -0.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Activities Uses | -1.26 | -1.17 | -0.47 | -0.51 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activities | 7.44-96.5% | 2.05 | 6.16-91.6% | -0.05 | 214.94 | -1.77 | 72.92+91050.0% | 0.08 |
| Exchange Rate Effect | -0.03-115.0% | -0.01-103.4% | 0.26 | -0.07 | 0.20 | 0.29 | -0.24 | 0.00 |
| Net Change in Cash | -2.71-101.3% | 14.69 | -25.11-143.0% | -246.16 | 210.96 | -29.58 | 58.42 | -23.80 |
| Free Cash Flow | -1.08 | -10.50 | -31.99 | -12.49 | -4.19 | -28.09 | -14.27 | -23.88 |
Revenue breakdown
USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Surgical & Medical Instruments & Apparatus | 125.81 | 176.03 | +39.9% | 100.0% |
| Total | 125.81 | 176.03 | +39.9% | 100.0% |
| Name | 2024 | 2025 | vs 2024 | 2025 share |
|---|---|---|---|---|
| Non-US | 10.77 | 13.30 | +23.5% | 7.6% |
| United States | 115.04 | 162.73 | +41.5% | 92.4% |
| Total | 125.81 | 176.03 | +39.9% | 100.0% |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 8.77% | 5.7M | 64.9M | 1.90M |
| 2026-10-15 | 11.30% | 7.3M | 64.9M | 1.81M |
| 2026-09-30 | 10.51% | 6.8M | 64.8M | 1.77M |
| 2026-09-15 | 8.68% | 5.6M | 64.8M | 1.91M |
| 2026-08-31 | 9.41% | 6.1M | 64.5M | 1.79M |
| 2026-08-14 | 10.52% | 6.8M | 64.4M | 1.61M |
| 2026-07-31 | 10.77% | 6.8M | 63.6M | 1.48M |
| 2026-07-15 | 9.22% | 5.9M | 63.7M | 1.50M |
| 2026-06-30 | 8.12% | 5.2M | 63.8M | 1.47M |
| 2026-06-15 | 6.61% | 4.2M | 63.7M | 1.33M |
| 2026-05-29 | 5.72% | 3.6M | 63.6M | 1.32M |
| 2026-05-15 | 5.47% | 3.5M | 63.6M | 1.34M |
| 2026-04-30 | 6.94% | 4.4M | 62.9M | 1.62M |
| 2026-04-15 | 9.44% | 5.5M | 58.8M | 1.59M |
| 2026-03-31 | 11.11% | 6.0M | 54.1M | 1.52M |
| 2026-03-13 | 10.28% | 5.6M | 54.1M | 1.33M |
| 2026-02-27 | 10.15% | 5.5M | 53.7M | 1.21M |
| 2026-02-13 | 8.49% | 4.6M | 53.7M | 1.12M |
| 2026-01-30 | 9.24% | 5.0M | 53.6M | 737.59K |
| 2026-01-15 | 6.49% | 3.5M | 53.6M | 632.86K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 25.00 | 33.00 | 36.00 | 33.54 | 450.4% | 9.00 | 9.00 | 0.990 | -0.046 | 0.002 |
| call | 30.00 | 28.00 | 31.00 | 23.71 | 368.6% | 20.00 | 0.00 | 0.972 | -0.102 | 0.006 |
| call | 35.00 | 23.20 | 26.20 | 21.00 | 315.3% | 4.00 | 0.00 | 0.966 | -0.099 | 0.007 |
| call | 40.00 | 18.50 | 21.40 | 20.20 | 265.4% | 20.00 | 3.00 | 0.933 | -0.153 | 0.011 |
| call | 45.00 | 14.70 | 17.40 | 11.30 | 255.2% | 71.00 | 0.00 | 0.866 | -0.252 | 0.019 |
| call | 50.00 | 10.80 | 13.20 | 13.20 | 224.0% | 224 | 22.00 | 0.776 | -0.346 | 0.026 |
| call | 55.00 | 7.30 | 9.30 | 8.50 | 194.9% | 620 | 13.00 | 0.665 | -0.464 | 0.032 |
| call | 60.00 | 5.40 | 6.30 | 6.00 | 180.8% | 532 | 115 | 0.559 | -0.459 | 0.035 |
| call | 65.00 | 3.60 | 4.70 | 3.77 | 178.9% | 914 | 229 | 0.432 | -0.402 | 0.035 |
| call | 70.00 | 1.90 | 3.10 | 2.50 | 185.4% | 101 | 89.00 | 0.332 | -0.379 | 0.032 |
| call | 75.00 | 0.70 | 2.55 | 1.50 | 201.7% | 1,158 | 1,141 | 0.271 | -0.376 | 0.029 |
| call | 80.00 | 0.20 | 1.40 | 0.80 | 186.1% | 120 | 60.00 | 0.179 | -0.273 | 0.023 |
| call | 85.00 | 0.15 | 2.05 | 0.44 | 210.1% | 49.00 | 59.00 | 0.164 | -0.292 | 0.022 |
| put | 25.00 | 0.00 | 2.15 | 0.06 | 283.4% | 46.00 | 46.00 | -0.010 | -0.043 | 0.002 |
| put | 30.00 | 0.00 | 0.65 | 0.33 | 276.2% | 21.00 | 15.00 | -0.028 | -0.099 | 0.006 |
| put | 35.00 | 0.10 | 1.05 | 0.35 | 222.0% | 55.00 | 14.00 | -0.034 | -0.095 | 0.007 |
| put | 40.00 | 0.05 | 1.20 | 0.59 | 205.2% | 103 | 33.00 | -0.067 | -0.149 | 0.011 |
| put | 45.00 | 1.00 | 1.40 | 1.23 | 205.0% | 120 | 32.00 | -0.134 | -0.247 | 0.019 |
| put | 50.00 | 0.80 | 2.70 | 2.28 | 203.9% | 3,588 | 2,033 | -0.224 | -0.340 | 0.026 |
| put | 55.00 | 2.85 | 5.40 | 3.93 | 228.5% | 6,353 | 1,134 | -0.335 | -0.457 | 0.032 |
| put | 60.00 | 5.50 | 8.10 | 6.40 | 232.0% | 125 | 22.00 | -0.441 | -0.452 | 0.035 |
| put | 65.00 | 7.70 | 10.40 | 9.69 | 210.0% | 18.00 | 1.00 | -0.575 | -0.376 | 0.034 |
| put | 70.00 | 12.00 | 13.90 | 0.00 | 209.4% | 0.00 | 0.00 | -0.668 | -0.371 | 0.032 |
| put | 75.00 | 15.50 | 18.30 | 0.00 | 226.2% | 0.00 | 0.00 | -0.729 | -0.368 | 0.029 |
| put | 80.00 | 20.00 | 22.70 | 0.00 | 236.1% | 0.00 | 0.00 | -0.821 | -0.264 | 0.023 |
| put | 85.00 | 24.60 | 27.40 | 0.00 | 251.4% | 0.00 | 0.00 | -0.836 | -0.282 | 0.022 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-12 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-11-12 | 8-K | Current report | 2026-11-12 | SEC |
| 2026-11-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-11-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-06 | SEC |
| 2026-11-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-06 | SEC |
| 2026-11-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-11-06 | SEC |
| 2026-11-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-11-09 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-26 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-22 | SEC |
| 2026-10-22 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-22 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-10-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-10-12 | SEC |
| 2026-10-13 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-21 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-18 | SEC |
| 2026-09-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-17 | SEC |
| 2026-09-17 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-15 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-15 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-11 | SEC |
| 2026-09-14 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-14 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-10 | SEC |
| 2026-09-11 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-11 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-10 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-10 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-08 | SEC |
| 2026-09-08 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-09-04 | 4 | Statement of changes in beneficial ownership of securities | 2026-09-02 | SEC |
| 2026-09-03 | 144 | Filing for proposed sale of securities under Rule 144. | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 2.36M | 2 |
| 2026-10 | 0 | 0 | 3.24M | 2 |
| 2026-09 | 0 | 0 | 7.79M | 11 |
| 2026-08 | 0 | 0 | 4.46M | 5 |
| 2026-07 | 0 | 0 | 863.21K | 2 |
| 2026-06 | 0 | 0 | 2.00M | 2 |
| 2026-05 | 0 | 0 | 918.27K | 2 |
| 2026-04 | 0 | 0 | 61.09M | 5 |
| 2026-03 | 0 | 0 | 2.42M | 4 |
| 2026-02 | 0 | 0 | 58.53M | 4 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 1.05M | 1 | 0 | 0 |
| 2025-11 | 0 | 0 | 0 | 0 |
Institutional holders
| Manager | % owned |
|---|---|
| Bain Capital Life Sciences Investors, LLC | 9.80% |
| WELLINGTON MANAGEMENT GROUP LLP | 9.12% |
| FMR LLC | 6.32% |
| BlackRock, Inc. | 6.03% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4.16% |
| BAMCO INC /NY/ | 3.74% |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.19% |
| Invesco Ltd. | 3.10% |
| Jupiter Topco LLC | 2.81% |
| ALLIANCEBERNSTEIN L.P. | 2.23% |
Funds
| Fund | % owned |
|---|---|
| VANGUARD HEALTH CARE FUND | 6.72% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.86% |
| iShares Russell 2000 ETF | 2.41% |
| VANGUARD SMALL-CAP INDEX FUND | 2.07% |
| BARON DISCOVERY FUND | 1.86% |
| Invesco Discovery Fund | 1.47% |
| VANGUARD SMALL-CAP VALUE INDEX FUND | 1.31% |
| Select Health Care Portfolio | 1.09% |
| Fidelity Small Cap Index Fund | 1.02% |
| Select Medical Technology and Devices Portfolio | 0.97% |
OakChart. HTFL. Cached 15 minutes. Terms